Effect of acute and long term potassium bromide administration on spatial working memory in rat

Faezeh Safdari, Mohammad Rabbani, Ali Hosseini-Sharifabad


Potassium bromide (KBr), an old antiepileptic agent, is illegally used in pharmaceutical or food industries to improve the product appearance. KBr has been proven to influence several pathways which are important in memory formation. Therefore, the present study aimed to evaluate the effect of KBr on spatial working memory using object recognition task (ORT). Rats received a single dose of KBr (50, 100 or 150 mg/kg), per oral, in acute treatment. KBr long term effects were also studied in animals receiving 50 mg/kg/day of KBr for 28 consecutive days. At the end of treatments, animals underwent two trials of ORT, five min each. In the first trial (T1), animals encountered with two identical objects for exploration. After 1 h, the animals were exposed to a familiar and an unfamiliar object (T2). The exploration times for discrimination (D) and recognition (R) as well as the frequency of exploration for any objects were determined. Acute administration of 150 mg/kg of KBr significantly decreased the discrimination and recognition indices (RI and DI) (P < 0.01) compared to the control. However, lower doses failed to influence the animals’ performance in the test. In addition, long term administration of KBr remarkably diminished the DI and RI and the frequency of exploration (P < 0.05). The results of this study indicate that acute doses of KBr as high as 150 mg/kg are required to hamper memory function in ORT. However, cognitive impairment occured with lower doses of KBr when the duration of treatment is extended.


Potassium bromide; Acute; Long term; Spatial working memory; Object recognition task

Full Text:



Ryan M, Baumann RJ. 1999. Use and monitoring of bromides in epilepsy treatment. Pediatr Neurol. 1999;21(2):523-528.

Ban TA. The role of serendipity in drug discovery. Dialogues Clin Neurosci. 2006;8(3):335-344.

Baird-Heinz HE, Van Schoick AL, Pelsor FR, Ranivand L, Hungerford LL, 2012. A systematic review of the safety of potassium bromide in dogs. J Am Vet Med Assoc. 2012;240(6):705-715.

Tan JS, Lin F, Tanouye MA. Potassium bromide, an anticonvulsant, is effective at alleviating seizures in the Drosophila bang-sensitive mutant bang senseless. Brain Res. 2004;1020(1-2):45-52.

Mangurten HH, Ban R. Neonatal hypotonia secondary to transplacentalbromism. J Pediatr. 1974;85(3):426-428.

Oloyede OB, Sunmonu TO. Potassium bromate content of selected bread samples in Ilorin, Central Nigeria and its effect on some enzymes of rat liver and kidney. Food Chem Toxicol. 2009;47(8): 2067-2070.

Alli AL, Nwegbu MM, Inyang BI, Nwachukwu KC, Ogedengbe JO, Onaadepo O, et al. Assessment of bread safety: determination of potassium bromate in selected bread samples in Gwagwalada, Abuja. Int J Health Nutr. 2013;4:15-20.

Bendig P, Maier L, Vetter W. Brominated vegetable oil in soft drinks–an underrated source of human organobromine intake. Food Chem. 2012;133:678-682.

Mathew J, Kumar TP, Khan RS, Paulose CS. Behavioral deficit and decreased GABA receptor functional regulation in the cerebellum of epileptic rats: Effect of Bacopa monnieri and bacoside A. Epilepsy Behav. 2010;17(4):441-447.

Sałat K, Podkowa A, Mogilski S, Zaręba P, Kulig K, Sałat R, et al. The effect of GABA transporter 1 (GAT1) inhibitor, tiagabine, on scopolamine-induced memory impairments in mice. Pharmacol Rep. 2015;67(6):1155-1162.

Abel T, Lattal KM. Molecular mechanisms of memory acquisition, consolidation and retrieval. Curr Opin Neurobiol. 2001;11:180-187.

Hosseini-Sharifabad A, Ghahremani MH, Sabzevari O, Naghdi N, Abdollahi, M, Beyer C, et al. Effects of protein kinase A and G inhibitors on hippocampal cholinergic markers expressions in rolipram-and sildenafil-induced spatial memory improvement. Pharmacol Biochem Behav. 2012;101(3):311-319.

Jafari-Sabet M, Jannat-Dastjerdi I. Muscimol state-dependent memory: Involvement of dorsal hippocampal μ-opioid receptors. Behav Brain Res. 2009;202(1):5-10.

Grayson B, Idris NF, Neill JC. Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat. Behav Brain Res. 2007;184(1):31-38.

Sik A, Nieuwehuyzen PV, Prickaerts J, Blokland A. Performance of different mouse strains in an object recognition task. Behav Brain Res. 2003;147:49-54.

Rutten K, Prickaerts J, Hendrix M, van der Staay FJ, Şik A, Blokland A. Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors. Eur J Pharmacol. 2007;558(1-3):107-112.

Hosseini-Sharifabad A, Rabbani M, Sharifzadeh M, Bagheri N. Acute and chronic tramadol administration impair spatial memory in rat. Res Pharm Sci. 2016;11(1):49-57.

Bertaina-Anglade V, Enjuanes E, Morillon D, Drieu la Rochelle C. The object recognition task in rats and mice: a simple and rapid model in safety pharmacology to detect amnesic properties of a new chemical entity. J Pharmacol Toxicol Methods. 2006;54(2):99-105.

Antunes M, Biala G. The novel object recognition memory: neurobiology, test procedure, and its modifications. Cogn Process. 2012;13(2):93-110.

Tsutsumi S, Akaike M, Ohno H, Kato N. Learning/memory impairments in rat offspring prenatally exposed to phenytoin. Neurotoxicol Teratol. 1998;20(2):123-132.

Frankel S, Medvedeva N, Gutherz S, Kulick C, Kondratyev A, Forcelli PA. Comparison of the long-term behavioral effects of neonatal exposure to retigabine or phenobarbital in rats. Epilepsy Behav. 2016;57:34-40.

Reeta KH, Mehla J, Gupta YK. Curcumin ameliorates cognitive dysfunction and oxidative damage in phenobarbitone and carbamazepine administered rats. Eur J Pharmacol. 2010;644 (1-3):106-112.

Stepien KM, Tomaszewski M, Luszczki JJ, Czuczwar SJ. The interactions of atorvastatin and fluvastatin with carbamazepine, phenytoin and valproate in the mouse maximal electroshock seizure model. Eur J Pharmacol. 2012;674(1):20-26.

Faught E. Topiramate in the treatment of partial and generalized epilepsy. Neuropsychiatr Dis Treat. 2007;3(6):811-821.

Balcar VJ, Erdö SL, Joó F, Kása P, Wolff JR. Neurochemistry of GABAergic system in cerebral cortex chronically exposed to bromide in vivo. J Neurochem. 1987;48(1):167-169.

Batool Z, Sadir S, Liaquat L, Tabassum S, Madiha S, Rafiq S, et al. Repeated administration of almonds increases brain acetylcholine levels and enhances memory function in healthy rats while attenuates memory deficits in animal model of amnesia. Brain Res Bull. 2016;120:63-74.

Francisa PT, Palmerb AM, Snapeb M, Wilcockc GK. The cholinergic hypothesis of Alzheimer's disease: a review of progress. J Neurol Neurosurg Psychiatry. 1999;66:137-147.

Kasa P, Toldi J, Farkas Z, Joó F, Wolff JR. Inhibition by sodium bromide of acetylcholine release and synaptic transmission in the superior cervical ganglion of the rat. Neurochem Int. 1987;11:443-449.

Buhot MC, Martin S, Segu L. Role of serotonin in memory impairment. Ann Med. 2000;32(3):210-221.

Seyedabadi M, Fakhfouri G, Ramezani V, Mehr SE, Rahimian R. The role of serotonin in memory: interactions with neurotransmitters and downstream signaling. Exp Brain Res. 2014;232(3):723-38.

Whitaker-Azmitia PM. Serotonin and brain development: role in human developmental diseases. Brain Res Bull. 2011;56:479-485.


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Creative Commons LicenseThis work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.